PRGO NYSE Week ended 31 Jul 2026

Weekly Investor Report

Perrigo Company PLC · Healthcare · Drug Manufacturers - Specialty & Generic

Latest close 10.11 USD
0.2% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -11.4% below the Trend Line and sits at 7.0% of its 52-week range. The latest completed week returned 0.2%, after a -8.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 28/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: earnings are due in 4d.

Setup score 23 out of 100
Latest Close 10.11 USD 31 Jul 2026
1W Return 0.2% latest completed week
4W Return -8.3% short-term follow-through
12W Return -11.4% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -11.4% below the Trend Line and sits at 7.0% of its 52-week range. The latest completed week returned 0.2%, after a -8.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1712-week average 0.11

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.17Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -8.3% over four weeks, -11.4% over 12 weeks, and -58.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.2%
4W-8.3%
12W-11.4%
26W-25.3%
52W-58.8%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.27Latest activity-pressure read.
Pressure change-73.3%Four-week change in activity pressure.
Leadership-34.16Latest relative-leadership reading.
RS change1.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength33/100Blend of value, momentum, and quality. Underlying universe rank 68; rank 1 is best.
Value79/100Relative valuation strength. Underlying universe rank 22; rank 1 is best.
Quality8/100Profitability and accounting quality. Underlying universe rank 93; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth21/100Revenue and earnings growth. Underlying universe rank 80; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
34.2%
Gross profit retained from each unit of revenue.
Operating margin
-37.1%
Operating profit retained from revenue.
Free-cash-flow margin
6.5%
Free cash flow generated from revenue.
Return on invested capital
-19.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-3.6%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-35.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
8.6%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
8.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-2.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

PRGO shows mixed options pressure with a 28/100 conviction score, put-call volume ratio of 0.90, expected move of 14.1%, and Sharemaestro trend signal inactive.

Conviction28/100
Expected move14.1%
Put/call volume0.90
Pressure12
Speculation2
Volatility92
Trend agreement50
Open options detail
Insider activity14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment49/100

Weighted news tone is neutral across 56 relevant articles.

3 positive · 45 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move14.1%Nearest-chain priced movement where available.
52-week drawdown-59.6%Distance below the 52-week high.
13-week volatility5.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+13.9%Week of 3 Apr.
Worst week-17.0%Week of 6 Mar.
Latest week+0.2%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains9
Flat weeks0
Modest losses5
Sharp losses7
Recent vol5.6%13-week weekly-return volatility.
Base vol7.4%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -6.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202610.11 USD0.2%11.41 USD21.55 USD0.27-34.1615.3MOff
24 Jul 202610.09 USD-5.9%11.51 USD21.68 USD0.48-35.1612.5MOff
17 Jul 202610.72 USD4.9%11.62 USD21.82 USD0.74-33.2213.8MOff
10 Jul 202610.22 USD-7.3%11.68 USD21.94 USD0.78-38.7115.3MOff
3 Jul 202611.02 USD10.8%11.76 USD22.06 USD1.00-34.5817.1MOff
26 Jun 20269.95 USD-2.9%11.82 USD22.17 USD0.97-40.9433.8MOff
19 Jun 202610.25 USD-6.7%11.91 USD22.29 USD0.80-41.8913.3MOff
12 Jun 202610.99 USD1.5%11.96 USD22.41 USD0.65-38.5122.6MOff
5 Jun 202610.83 USD-2.0%12.02 USD22.53 USD0.34-40.3314.1MOff
29 May 202611.05 USD1.1%12.11 USD22.64 USD0.19-41.8211.2MOff
22 May 202610.93 USD5.7%12.38 USD22.75 USD0.14-42.8211.7MOff
15 May 202610.34 USD-9.4%12.69 USD22.86 USD0.08-46.5613.1MOff
8 May 202611.41 USD-1.8%13.01 USD22.97 USD0.03-42.0813.8MOff
1 May 202611.62 USD0.8%13.29 USD23.09 USD-0.07-40.8710.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.